RE:RE:RE:RE:Comparing DM to other AI and Healthcare Stocksthemason wrote: How much of that is attributed to Ai, very little, hence the problem.
It is true that their AI and Technology revenue may continue to be under their AI and Technology of 2020 for the first three quarters. However, as you will see from the numbers below DM is ahead of their 2020 total AI and Tech revenue for the year end total for 2021.
AI and Tech 2020 Three months ended June 30, 2020
$2,526,686 Three months ended Sept. 30, 2020
$391,362 Nine months ended Sept. 30, 2020
$3,915,411 Total AI and Tech for 2020 =
$4,101,967 AI and Tech (2021) Three months ended March 31, 2021
$388,939 Three months ended June 30, 2021
$771,899 Six months ended June 30, 2021
$1,160,838 Three months ended Sept 30, 2021
Added $250,000 AI contract on August 26
Added $900,000 AI contract Sept. 22
=
$1,150,000 (Do not know any additional tech that may be added to these numbers) Nine months ended Sept 30, 2021
Estimated $2,310,838 (Do not know any additional tech that may be added to these numbers) So based on these number DM will be
$3,915,411 (2020) - $2,310,838 (2021) = 1,604,573 less in AI and Tech for Q3
Total AI and Tech estimated based on what we know so far for 2021 Added $950,000 AI contract on October 26
Added $750,000 AI contract on November 9
Added $1,000,000 AI contract on November 12
=
$5,010,838 (again, this does not include any other known tech added to the AI numbers) So DM is ahead in their AI and tech for 2021 by about $1,000,000 based on what we know so far.